Crinetics Pharmaceuticals, Inc.: cashflow_financing
| Value | {"amount": 1014659000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | Crinetics Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:04:14.962457+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/324a588f-b235-4605-8e99-4c51c4bcbb21
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001658247-26-000012Retrieved: 2026-08-19T17:04:14.962457+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001658247/cashflow-financing/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/324a588f-b235-4605-8e99-4c51c4bcbb21
History
- supersedes {"amount": 1010435000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0000950170-25-029050)